Member Info for KUMS

Just seen yr post & will listen to it tomorrow.

Only few Pis sold but this is the time to be in as contracts should start rolling in. MMs tried to hide sp behind small sells but has recovered well. It is very good time to be in this one.

Someone snapped up 250k shares at 7p this morning!

Yes and NHS trials should bring bring big orders if we are successful. With Leicester Uni giving a grant, it looks positive. I was also reading a blog where nurses gave a very positive feedback. And just look at the countries we are in. Middle East should be big imo due to cost savings. Hold tight!

So many buys at 13p but sp not moving. This is likely to stay here until all Henderson's sells are bought. Then those who got in today should see decent rise and dividend.

Even inside 6p, sp was kept low to fill orders. I also noticed then that buys exceeded sells one day but sp was down. Then late trades would appear later and orders were filled. It's difficult to tell with buys mixed as sells, but I do not think we should be down today! It has just given me opportunity to add at 7.25. NHS trials seems to be going on very well and hospitals seems to be giving a thumps up! This should result in big orders! That's just the UK! We have USA, Middle East, South Africa etc. DYOR. Most Pis will miss this opportunity as shares will be eaten up by Institutional Investors.

I am seeing lots of people taking position at 13P. Bargain due to Henderson's selling some of their holdings. RNS out.

I got 100k at 13p today. This was bargain basement for Simon Thompson of IC at 18p! It surely is now!

Anthony Sethill, chief executive of Sensium’s parent company Toumaz Group, said the patches could save the NHS more than £500 million a year on a £50 million annual investment, mainly by slashing the number of days patients spent in hospital. A six-month US study found that the patch almost halved the time patients who experienced a serious and unexpected medical episode spent in hospital. Professor Sir John Tooke, president of the Academy of Medical Sciences, said: ‘Vital-signs monitoring is something that is not done particularly well in NHS hospitals. ‘Human factors get in the way: staff get distracted or called to what they perceive to be more urgent matters. The proper application of this type of technology will be better than human measurement alone. I think it’s the future – as long as the technology is robust and subject to rigorous trials.’ Julie Bailey, founder of the Cure The NHS pressure group, welcomed the device. She said: ‘If this could help save money and allow the frontline staff to focus on our other medical needs, then we should embrace what technology has to offer.’

13p to buy, so brilliant just for the dividends!

http://www.bbc.co.uk/news/health-28415753

Very good opportunity to buy. I topped up but NT only for the amount I wanted to buy. Professor Timothy Coats, Professor of Emergency Medicine, Department of Cardiovascular Sciences, University of Leicester and Director of the Leicester Diagnostics Development Unit, said: ”SensiumVitals® is a ground-breaking system in the world of patient monitoring. The ability to take measurements every two minutes allows clinicians quickly to identify early signs of patient deterioration. “By working with Sensium Healthcare on its next generation product, our joint aim is to develop system enhancements which are fully aligned with the needs of patients, clinicians and the broader NHS.”

SP held very well with another rise in 2 days. We could see big late buys at close again.

Yesterday 550k shares were bought for 7.75. Someone paid above the odds to be in. We saw that last month when someone paid 6p when we could buy at 5.60. Something tell me we will move up in decent time.

Bought 60k more share here today.

Taken a punt in trp. Been in there before many times in the last 8 years! This one will make me the most money.

SP holding very well. We should get more coverage in the press regarding NHS trials.

Professor Timothy Coats, Professor of Emergency Medicine, Department of Cardiovascular Sciences, University of Leicester and Director of the Leicester Diagnostics Development Unit, said: ”SensiumVitals® is a ground-breaking system in the world of patient monitoring. The ability to take measurements every two minutes allows clinicians quickly to identify early signs of patient deterioration. “By working with Sensium Healthcare on its next generation product, our joint aim is to develop system enhancements which are fully aligned with the needs of patients, clinicians and the broader NHS.”

Anthony Sethill, CEO of Toumaz Group, said on yesterday's rns: “This funding is recognition of the potential of SensiumVitals® to improve patient safety and deliver economic benefits to hospitals. The roll-out of the system is just beginning – and we are already greatly encouraged by the interest shown in the UK and abroad. “To ensure that SensiumVitals® maintains its leadership position in the field of wireless monitoring, we will continue to place a heavy emphasis on innovation. In the University of Leicester, we have found the ideal partner to guide us in this process.”

With health & DAB news, we are here to grow. Soon this will be recommended by an expert and with lots of news flow to come over months and years, I am pleased to be in inside 10p. http://www.bbc.co.uk/news/health-28415753 http://www.toumaz.com/frontier-silicon